Donna Percy

Sterling Research Group, LtdCincinnati, Ohio - 45219 |
- CLINICAL TRIALS 1
- CONDITIONS4
- INTERVENTIONS2
- SINCE2009

Safety & Effectiveness on Vascular Structure and Function of ACZ885 in Atherosclerosis and Either T2DM or IGT Patients
December 2009 - March 2012
Diabetes Mellitus
Atherosclerosis
Diabetes Mellitus, Type 2
Prediabetic State
Placebo
Acz885 (Canakinumab)



